ArticleInternational journal of colorectal disease2019

Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease.

Youn I Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.